SUMMARY
In this webinar, Ophthalmologist Dr. Elvira Gur Lautman introduces the medical potential of InMode’s Envision platform for one of today’s most prevalent conditions: chronic dry eye. Using a compelling patient case as the starting point, the session explores the limitations of traditional therapies like artificial tears, compresses, and cyclosporine, while presenting a new approach through Envision’s ophthalmic handpieces. The talk emphasizes how safe, targeted RF and IPL modalities can improve meibomian gland function, reduce inflammation, and offer patients both symptom relief and measurable improvements.
TOPICS COVERED
- Understanding the tear film and why meibomian gland dysfunction drives evaporative dry eye.
- The economic burden of dry eye and limitations of current treatments like artificial tears and drops.
- Role of Lumecca-I (IPL) in addressing eyelid inflammation and demodex parasites, and its limitations.
- Advantages of Forma-I (RF) for safe, shield-free, controlled heating of eyelids to restore gland function.
- Clinical trial results, patient outcomes, and how Envision enables technician-performed dry eye therapy.
